MedPath

Panag Pharma, Inc.

Panag Pharma, Inc. logo
🇨🇦Canada
Ownership
Subsidiary
Established
2014-01-01
Employees
11
Market Cap
-
Website
http://www.panagrx.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Topical Use of 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin for Pain Caused by Osteoarthritis Of The Knee

Phase 2
Completed
Conditions
Pain
First Posted Date
2017-05-15
Last Posted Date
2020-01-06
Lead Sponsor
Panag Pharma Inc.
Target Recruit Count
56
Registration Number
NCT03152578
Locations
🇨🇦

QEII Health Sciences Centre, Halifax, Nova Scotia, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.